Intellia Therapeutics Inc (NASDAQ:NTLA)

117.25
Delayed Data
As of Dec 07
 +16.49 / +16.37%
Today’s Change
43.86
Today|||52-Week Range
202.73
+115.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues7.4M7.9M10.4M11.1M
 
 
 
 
 
Depreciation And Amortization1.2M1.2M1.3M1.3M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses30.4M27.4M32.9M37.3M
 
 
 
 
 
Research And Development23.2M19.9M23.7M25.5M
 
 
 
 
 
Total Operating Expenses31.5M28.6M34.2M38.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-24.1M-20.7M-23.8M-27.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.7M-19.1M-21.9M-25.7M
 
 
 
 
 
Net Income-22.7M-19.1M-21.9M-25.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS43.2M44.2M45.2M45.8M
 
 
 
 
 
Shares To Calculate EPS Diluted43.2M44.2M45.2M45.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.53-$0.43-$0.49-$0.56
 
 
 
 
 
EPS Diluted-$0.53-$0.43-$0.49-$0.56